Daily Cosmetic Research Analysis
Top findings today span surgical, mechanistic, and formulation advances in cosmetic and dermatologic science: a large systematic review clarifies optimal surgical strategies for advanced hidradenitis suppurativa with implications for recurrence and cosmetic outcomes; a supramolecular avobenzone complex markedly improves UVA photostability and SPF; and mechanistic biochemistry maps hydroquinone oxidation pathways that may underlie exogenous ochronosis.
Summary
Top findings today span surgical, mechanistic, and formulation advances in cosmetic and dermatologic science: a large systematic review clarifies optimal surgical strategies for advanced hidradenitis suppurativa with implications for recurrence and cosmetic outcomes; a supramolecular avobenzone complex markedly improves UVA photostability and SPF; and mechanistic biochemistry maps hydroquinone oxidation pathways that may underlie exogenous ochronosis.
Research Themes
- Surgical strategies and cosmetic outcomes in chronic inflammatory skin disease
- Photoprotection innovation via supramolecular filter stabilization
- Mechanistic toxicology of depigmenting agents and pigmentation biology
Selected Articles
1. Surgical Interventions in Advanced Hidradenitis Suppurativa: A Systematic Review.
Across 136 studies (5,646 procedures), primary closure had the highest recurrence (38%) and complication (29.4%) rates, whereas laser-assisted surgery had the lowest recurrence (5.7%) and complications (2.2%). Wide excision reduced recurrence versus primary closure but had the highest cosmetic dissatisfaction, underscoring the need for individualized operative planning in Hurley II–III HS.
Impact: This systematic synthesis directly informs surgical decision-making in advanced HS by quantifying recurrence, complications, and cosmetic dissatisfaction across modalities, highlighting laser-assisted approaches as promising.
Clinical Implications: Avoid primary closure when durable disease control is desired; consider laser-assisted surgery or wide excision, counseling patients on trade-offs between recurrence risk and cosmetic dissatisfaction to tailor operative plans.
Key Findings
- Primary closure showed the highest recurrence (38.0%) and complication (29.4%) rates among modalities.
- Laser-assisted surgery achieved the lowest recurrence (5.7%) and complication (2.2%) rates.
- Wide excision (n=1,923) had moderate recurrence (17.2%) but the highest cosmetic dissatisfaction.
- Flaps and grafts had fewer recurrences than primary closure but higher complication rates.
Methodological Strengths
- Comprehensive MEDLINE and EMBASE search with 136 included studies.
- Comparative synthesis across multiple surgical modalities with patient-centered outcomes.
Limitations
- Predominantly observational evidence with heterogeneity across studies.
- Cosmetic dissatisfaction measures likely varied and were not standardized.
Future Directions: Prospective, standardized outcome studies and randomized comparisons of laser-assisted versus wide excision approaches are needed, including validated cosmetic and quality-of-life endpoints.
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, immune-mediated skin disorder affecting intertriginous areas, frequently leading to painful nodules, abscesses, sinus tracts, and scarring. In patients with moderate-to-severe disease (Hurley Stages II and III), surgical intervention is frequently required to achieve durable disease control. OBJECTIVE: To compare and evaluate the surgical interventions employed in Hurley Stage II and III HS by evaluating recurrence rates, postoperative complications, and patient-centred outcomes across different operative modalities. METHODS: A comprehensive search of MEDLINE and EMBASE identified studies reporting surgical outcomes in Hurley Stage II and III HS. English-language studies describing postoperative recurrence, complications, and patient-centred outcomes stratified by surgical intervention were included. Of 647 studies screened, 136 studies were included. RESULTS: A total of 136 studies were included (5,646 procedures). Primary closure had the highest recurrence (38.0%) and complication rates (29.4%). Wide excision (n = 1923) showed moderate recurrence (17.2%) and the highest cosmetic dissatisfaction. Laser-assisted surgery had the lowest complication rate (2.2%) and recurrence rate (5.7%). Flaps and grafts showed higher complication rates but fewer recurrences than primary closure. CONCLUSION: Surgical outcomes in advanced HS vary by intervention. Primary closure is associated with the highest rates of recurrence and complications, while wide excision and laser-assisted surgery may offer improved disease control. These findings support individualized surgical planning in Stage II and III HS.
2. Supramolecular avobenzone sunscreen: a promising method for enhancing UV protection and photostability.
A dual supramolecular assembly linking avobenzone with ferulic acid and ergothioneine achieved up to 8-hour photostability and boosted SPF by 15.93-fold, while maintaining strong antioxidant activity, biocompatibility, and negligible skin permeability. This formulation strategy directly addresses avobenzone’s key limitation and may enable safer, more durable UVA protection.
Impact: Demonstrates a practical supramolecular strategy to markedly enhance a widely used UVA filter’s stability and performance, with immediate relevance to sunscreen formulation and consumer safety.
Clinical Implications: If validated in vivo, supramolecular avobenzone systems could reduce photodegradation, maintain UVA coverage longer, and potentially decrease photoirritation risks, informing next-generation photoprotection products.
Key Findings
- Dual supramolecular AVB-FA-EGT enhanced photostability up to 8 hours.
- Sun protection factor increased by 15.93-fold compared with avobenzone alone.
- Formulation showed strong antioxidant properties, biocompatibility, negligible permeability, and favorable safety profile.
- Provided broad-spectrum UV resistance via noncovalent assembly.
Methodological Strengths
- Rational supramolecular design integrating antioxidant cofactors to stabilize avobenzone.
- Multi-parameter assessment including photostability, SPF, antioxidant capacity, permeability, and safety.
Limitations
- Evidence is preclinical; in vivo human efficacy and tolerability data are not reported.
- Long-term stability in finished formulations and regulatory acceptance remain to be established.
Future Directions: Conduct in vivo photoprotection and irritation studies, evaluate real-world photostability in finished products, and compare against industry-standard stabilizers.
The damages caused by ultraviolet (UV) radiation to the skin have become a global public health concern. Long-term exposure to UV radiation can lead to serious consequences, such as sunburn, tanning, photoaging, and even skin cancer. As a key product for resisting UV damage, sunscreen has attracted much attention for its effectiveness and safety. Avobenzone is an important chemical sunscreen agent that is widely used in sunscreen products due to its excellent protective effect against long-wave UVA radiation. However, avobenzone has drawbacks such as poor photostability. Therefore, we linked avobenzone, ferulic acid, and ergothioneine together through intermolecular forces to form dual supramolecular avobenzone-ferulic acid-ergothioneine (AVB-FA-EGT). The dual supramolecular AVB-FA-EGT exhibited enhanced broad-spectrum UV resistance, photostability (up to 8 h), and sun-protection effect (sun protection factor increased by 15.93 times). In addition, the dual supramolecular AVB-FA-EGT exhibited strong antioxidant properties and biocompatibility, negligible permeability, and outstanding safety performance. Supramolecular avobenzone provides a new approach for the development of high-performance, bio-based, photoprotective sunscreens.
3. Mechanistic Insights into Tyrosinase-Catalyzed Metabolism of Hydroquinone: Implications for the Etiology of Exogenous Ochronosis and Cytotoxicity to Melanocytes.
Hydroquinone undergoes tyrosinase-mediated oxidation via dual pathways: an HBQ/HHQ route yielding HQ-eumelanin and, in the presence of cysteine, a BQ pathway yielding HQ-pheomelanin. 4-aminophenol was identified as a degradation product and proposed as a novel marker of HQ oxidation, suggesting continuous tyrosinase-driven HQ oxidation could contribute to exogenous ochronosis.
Impact: Provides a mechanistic map and a measurable marker for hydroquinone oxidation, advancing understanding of exogenous ochronosis risk from skin-lightening products.
Clinical Implications: Supports cautious, time-limited HQ use and monitoring; motivates alternative depigmenting strategies and offers 4-aminophenol as a potential in vitro marker to evaluate product oxidation propensity.
Key Findings
- Tyrosinase catalyzes HQ hydroxylation via an HBQ→HHQ pathway producing HQ-eumelanin-like products.
- In the presence of cysteine, oxidation shifts to a benzoquinone pathway yielding HQ-pheomelanin-like products.
- 4-aminophenol was identified after hydroiodic acid hydrolysis of HQ-PM and proposed as a novel marker of HQ oxidation.
- HQ acts both as a pseudo substrate (redox exchange with dopaquinone) and a true substrate for tyrosinase, enabling dual melanin-like product formation.
Methodological Strengths
- HPLC and HPLC-electrochemical analyses identified intermediates and degradation products, supporting pathway elucidation.
- Use of cysteine modulated pathway choice, strengthening causal mechanistic inference.
Limitations
- In vitro system using mushroom tyrosinase may not fully recapitulate human skin enzymology and microenvironment.
- No in vivo validation or direct clinical correlation with ochronosis severity was presented.
Future Directions: Validate pathways and AP marker in human skin models and clinical specimens; assess product formulations for HQ oxidation propensity under realistic use conditions.
The metabolism of hydroquinone (HQ) by tyrosinase presents significant biochemical and dermatological challenges, particularly due to its association with adverse effects such as exogenous ochronosis (EO). Despite its widespread use in skin-lightening products, the detailed mechanistic pathways of HQ metabolism by tyrosinase remain inadequately understood. This study aims to elucidate the mechanistic insights into the tyrosinase-catalyzed metabolism of HQ, leading to the production of HQ-eumelanin (HQ-EM) and HQ-pheomelanin (HQ-PM). We employed HPLC analysis to detect key intermediates and final metabolites. Results show that mushroom tyrosinase catalyzes the hydroxylation of HQ to 2-hydroxyhydroquinone (HHQ) via the 2-hydroxybenzoquinone (HBQ) pathway, giving rise to HQ-EM. However, in the presence of cysteine, a shift from HBQ to the benzoquinone (BQ) pathway occurs, giving rise to HQ-PM. Hydroiodic acid hydrolysis of HQ-PM and subsequent HPLC-electrochemical analysis identified 4-aminophenol (AP) as degradation product, thereby serving as a novel marker to monitor HQ oxidation in vitro. These results indicate that HQ functions both as a "pseudo" substrate for tyrosinase-undergoing redox exchange with dopaquinone to form BQ-and as a true substrate, yielding HBQ. This dual role contributes to the formation of HQ-EM and HQ-PM. It would be possible that EO is caused by a continuous oxidation of HQ mediated by tyrosinase activity in the skin.